SCHEMBL18696985

SCHEMBL18696985

O=C(O)[C@@H](CCCCc1ccccc1)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.57
ITGAV P06756 1/20 0.57
SLC1A3 P43003 1/20 0.52
SLC1A2 P43004 1/20 0.52
SLC1A1 P43005 1/20 0.52
ITGA2B P08514 3/20 0.51
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
MMP2 P08253 6/20 0.47
MMP9 P14780 6/20 0.47
MMP1 P03956 3/20 0.46
MMP13 P45452 3/20 0.46
MMP8 P22894 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
TMPRSS11D O60235 2/20 0.46
MMP7 P09237 3/20 0.46
MMP3 P08254 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12044849 0.96 SLC1A3 (0.54) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL18697083 0.92 ITGB3 (0.56) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL18697090 0.92 ITGB3 (0.56) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL1329533 0.90 SLC1A3 (0.56) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL12044862 0.88 ITGB3 (0.52) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL30309011 0.87 ITGB3 (0.65) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL6818050 0.86 ITGB3 (0.53) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL600046 0.86 ALDH1A1 (0.52) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL6818782 0.83 ITGB3 (0.52) ITGB3ITGAVSLC1A3SLC1A2SLC1A1
SCHEMBL23039617 0.83 HDAC2 (0.52) ITGB3ITGAVSLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611290-B2 Trypsin-like serine protease inhibitors, and their preparation and use THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2017-04-04 US disclosed